Programme | Time (SGT) |
---|---|
Welcome Remarks by the Conference Chairman and SHC partners | |
Chronic Hepatitis B symposium Chairs: Prof. Junqi NIU, Prof. Harry Janssen, Prof. Rino Gani |
|
Advances in HBV Cure 2024 – Prof. Man Fung Yuen, Hong Kong View Bio |
|
New guidelines for CHB – Prof. Jidong Jia, China View Bio |
|
Debate: Should treatment be expanded Yes: Prof. Man Fung Yuen, Hong Kong View Bio No: Prof. Heiner Wedemeyer, Germany View Bio |
|
Stopping nucleoside analogue therapy: worth the risk? – Prof. Harry Janssen, Netherlands View Bio |
|
Update on management of HBV flares – Prof. Teerha Piratvisuth, Thailand View Bio |
|
Round table discussion/Case discussion | |
GSK Meet the Experts Tea Break The building blocks of functional cure in HBV: Understanding the mechanisms and clinical considerations |
|
Welcome and introduction – Prof. Lai Wei View Bio |
|
The cornerstone: Defining the mechanisms needed to target functional cure – Dr. Kosh Agarwal View Bio and Prof. Lai Wei View Bio |
|
The keystone: Measuring, monitoring and managing – Dr. Kosh Agarwal View Bio and Prof. Lai Wei View Bio |
|
The capstone: Making functional cure last – Dr. Kosh Agarwal View Bio and Prof. Lai Wei View Bio |
|
Summary and close – Prof. Lai Wei View Bio |
|
Delta Cure Symposium Chairs: Prof. Teerha Piratvisuth , Prof. Khin Maung Win |
|
What is the prevalence of delta hepatitis and how do you diagnose it – Prof. Pei Jer Chen, Taiwan View Bio |
|
What is delta cure and how to achieve it? – Prof. Pietro Lampertico, Italy View Bio |
|
Treatment options for delta cirrhosis – Prof. Heiner Wedemeyer, Germany View Bio |
|
Round table/case discussion | |
First GSK Symposium (lunch) Functional cure in HBV: Going the distance |
|
Warm up: Introduction and housekeeping – Prof. Tatsuya Kanto View Bio |
|
The functional cure triathlon: HBsAg loss, HBV-DNA suppression, and immune restoration – Prof. Lai Wei View Bio |
|
Personal goals: What could functional cure mean for people living with CHB? – Prof. Thomas Tu View Bio |
|
On the starting line: Current strategies to achieve functional cure – Prof. Tatsuya Kanto View Bio |
|
Taking the torch: Future strategies that could achieve functional cure – Dr. Kosh Agarwal View Bio |
|
Q&A – All Faculty |
|
MASLD Symposium Chairs: Prof. Yock Young Dan, Dr. Poh Seng Tan, Dr. Yin Mei Lee |
|
NAFLD, MAFLD, MASLD – practical implications of a name change. – Dr. George Goh, Singapore View Bio |
|
Community screening and care pathways in Fatty Liver Disease – Prof. Wah Kheong Chan, Malaysia View Bio |
|
Selecting patients for pharmacological treatment – Prof. Sven Francque, Belgium View Bio |
|
Debate: Vitamin E for NAFLD Yes: Prof. Arun Sanyal, USA View Bio No: Prof. Vincent Wong, Hong Kong View Bio |
|
Pearls and pitfalls on how to use GLP1 agonists – Dr. Mark Muthiah, Singapore View Bio |
|
Summary of the Second Singapore MASLD Symposium – Prof. Arun Sanyal, USA View Bio |
|
Round table/case discussion | |
Fireside Chat with Hepatology experts: career pearls for clinicians and researchers Moderator: Dr. Daniel Huang |
|
Featuring Prof. Rajender Reddy, View Bio Dr. Anand V Kulkarni, India View Bio & Prof. Arun Sanyal, USA View Bio | |
End of day 1 |
SHC 2024 Scientific Programme
July, 2024
26
July, 2024
27
Programme | Time (SGT) |
---|---|
HCC Symposium Chairs: Dr. Edhel Tripon, Dr. Wei Lyn Yang, Adj. A/Prof. Chee Cheng Ean |
|
Hepatocellular surveillance: Barriers, gaps and new strategies – Dr. Ken Liu, Australia View Bio |
|
Role of non-invasive tests in NASH and HCC risk – Dr. Daniel Huang, Singapore View Bio |
|
Debate: Adjuvant therapy for HCC Cure Yes: Prof. Pierce Chow, Singapore View Bio No: Prof. Glenn Bonney, Singapore View Bio |
|
Updates in systemic therapy for HCC: the way forward – Adj. A/Prof. Chee Cheng Ean, Singapore View Bio |
|
Round-table /case discussion | |
Tea Break | |
Other Liver Diseases Chairs: Dr. How Cheng Low, Dr. Kieron Lim, Prof. Bettina Hanssen |
|
The forgotten disease: Alcoholic liver disease & MetALD – Prof. Ajay Duseja, India View Bio |
|
Difficult to treat autoimmune hepatitis – Prof. Atsushi Tanaka, Japan View Bio |
|
Biliary cirrhosis and sclerosing cholangitis: Update – Prof. Atsushi Tanaka, Japan View Bio |
|
When should we consider rare liver diseases and how to diagnose it? – Prof. Bettina Hanssen, Holland View Bio |
|
Round table/case discussion | |
Lunch | |
Advanced Liver Disease Management for the practising gastroenterologist/hepatologist Chairs: Dr. Rinaldi Lesmana, Prof. Raj Reddy |
|
Hepatorenal syndrome and point of care ultrasound. – Dr. Anand V Kulkarni, India View Bio |
|
Acute on chronic liver failure – Prof. Ajay Duseja, India View Bio |
|
Preventing progression and complications of cACLD. – Dr. Ken Liu, Australia View Bio |
|
When to refer patients for liver transplantation – Dr. Ruveena Bhavani Rajaram, Malaysia View Bio |
|
Futility in liver transplantation – Prof. Rajender Reddy, USA View Bio |
|
Round table/cases discussion | |
Closing comments from the Chairman |